The policy stream "Global Health Policy" focuses on the most important challenges of the sector, ranging from pandemics to health regulation, from technological innovation to ethics, preparing the next generation of leaders in the field. The sector already represents a rising share of world GDP, and is expected to grow even more in the near future due to several trends: development, aging population, social changes, emerging risks, technological innovation, etc. Developed in close consultation with major public institutions and business firms, the degree prepares students for careers in this rapidly-changing sector.
In order to fit with the sector's job market, the programme is based on a comparative approach and offers two different tracks:
- a French track, entitled Santé (fr.), taking into account the specificities of the French job market (fr);
- an English track, described below, preparing for global careers.
While the dramatic advances of the last several decades in transportation, communication, and technology have created unparalleled opportunities to improve the health of the world's population, including the poorest, they have also simultaneously put the planet at risk for large-scale disasters and pandemics. Meanwhile, a large eco-system of private firms (pharmaceuticals, medical devices, medical equipment, IT, hospitals), public-private partnerships (the Global Fund, GAVI), international organizations (UNITAID, the World Bank, WTO), private foundations (Bill & Melinda Gates Foundation), NGOs (Doctors without borders, Care) and consultancies (communication, lobbying, market access) has grown and dramatically changed the past landscape.
This policy stream addresses today's most important global and domestic health challenges and prepares its graduates for positions across a range of organizations, from the public and private, national, bilateral to the multilateral. In doing so, the program offers a plurality of perspectives, necessary to evolve within today's dynamic global health policy landscape. Students take courses that cover essential areas - health policy, health economics and law, health from a global perspective, biostatistics and epidemiology, and IT and connected Health – providing a comprehensive understanding of a sector marked by its constantly changing nature, including health 2.0. Students also gain fundamental knowledge of the economic and juridical aspects of health industries and the social politics within which they are contextualized. Of no less importance, participants are equipped with know-how in the management of health institutions, organizations, and services. This policy stream also maintains a multidisciplinary lens where health can be understood including: biomedicine; psychosocial/social and behavior/anthropology; development/political economy; and ethics/history/humanities.
The unique multidisciplinary approach of this policy stream trains students to implement integrative problem solving for complex global and domestic health issues, as well as attain integrative understandings of diseases and conditions that afflict developing and developed countries. In response to a sector which demands creativity and innovation, this policy stream provides a future generation of professionals with the necessary tools, knowledge, and know-how.
- Health Economics
- Health Law and Regulation
- Health in a Global Perspective
- Contemporary Health Issues and Challenges
- Health Policies and Organizations
- Biostatistics and Epidemiology
- Digital Health Innovation and Industries
Graduates from this policy stream pursue careers in a variety of important positions in the health domain, from hospital sectors, public and private, consulting agencies, health agencies, administrations, industries, or in international organizations specialized in the field of health, as well as other community-based and research/academic institutions across the globe.
Master in Public Policy:
Master in European Affairs: programmes will be available for 2017 intake.
Programme 2015-2017 (in French)
Master in Public Policy:
Henri Bergeon - co-director of LIEPP's "Health Policy" Reasearch Group, scientific coordinator of the Sciences Po Health Studies Chair, and co-director of the "Health" subject at the "Presses" of Sciences Po.
He developed his research activities at CNRS and at Sciences Po on health policies and on the transformation of practices in the medical profession. He studies diverse subjects including illicit drugs, alcohol, obesity, medical research and public health policy by using tools from the sociology of public action and the sociology of organizations. He also focuses on the role of knowledge in professional practice and its affect on the way collective opinions are formed.
Daniel Benamouzig is director of research at the CNRS and co-director of the LIEPP "Health Policy" Research Group. He is also the deputy director of the AVIESAN Alliance Institute for Public Health, in charge of coordinating major public operators in this area.
His research ranges from public health and economic policy to institutional governance. He studied the history of health economics and transformations in the regulation of the sector. He continues to conduct research in the field of economic sociology and political sociology of healthcare and he is particularly interested in institutional changes and the mobilization of knowledge in this field.
Louis-Charles Viossat - Inspector General at the French general inspectorate for social affairs (IGAS).
In his functions, he evaluates policies and legislations on health, life sciences, labor and social security. He also audits public, non-profit and private institutions in these areas. Throughout his distinguished career, he has evolved in both the public and the private sector, at the French and global levels. He has worked for the World Bank, has been the chief of staff ofthe French minister of Health, and the deputy chief of staff to the Prime Minister as well as CEO of ACOSS, French social security's "bank". He has also been French Ambassador in charge of the fight against HIV/AIDS and communicable diseases. In the private sector, he has been working at Eli Lilly as corporate affairs director, Abbott as Government affairs director for Western Europe and Canada, and Abbvie, a world leading biopharmaceutical company as Vice-President for International Government Affairs.